Valuation: Light AI Inc.

Market Cap 61.75L 44.26L 39.64L 36.46L 33.04L 42Cr 62.91L 4.35Cr 1.75Cr 22Cr 1.66Cr 1.63Cr 70Cr P/E 2024
-0.75x
P/E 2025 -0.89x
Enterprise Value -3L -2L -2L -2L -2L -1.91Cr -3L -19.75L -8L -1Cr -8L -7L -3.17Cr EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
83.31%
Yield 2024 *
-
Yield 2025 -
1 day+11.11%
1 week-16.67%
Current month-67.74%
1 month-70.59%
3 months-73.68%
6 months-56.52%
Current year-58.33%
1 week 0.04
Extreme 0.045
0.07
1 month 0.02
Extreme 0.015
0.16
Current year 0.02
Extreme 0.015
0.44
1 year 0.02
Extreme 0.015
0.44
3 years 0.02
Extreme 0.015
1.23
5 years 0.02
Extreme 0.015
1.23
10 years 0.02
Extreme 0.015
1.23
Date Insider Type Main position Quantity % Market Cap. Importance
19/08/26 Option

Director

-5,00,000 0.4080%
19/08/26 Other 0 0% -
19/08/26 Other 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
+11.11%-16.67%-68.75% - 44.16L
-1.72%+3.02%+24.84%+61.56% 26TCr
-2.00%+1.08%+8.51%+23.61% 17TCr
-3.73%-2.67%-19.64%+66.81% 16TCr
-1.66%-8.76%-58.15%-15.23% 6.19TCr
-2.57%+2.13%+11.27%+49.10% 5.44TCr
0.00%+2.71%-13.09%-6.48% 5.33TCr
-3.47%+0.56%+22.12%+70.16% 5.11TCr
+0.84%-2.97%+9.17%+65.13% 5.02TCr
-3.61%+1.57%+34.72%+89.05% 4.72TCr
Average -0.60%-0.79%-4.90%+44.86% 9.03TCr
Weighted average by Cap. -1.95%+2.44%+4.90%+47.54%

Financials

2024 2025
Net sales - -
Net income -1.31Cr -93.89L -84.09L -77.35L -70.09L -89Cr -1.33Cr -9.22Cr -3.7Cr -47Cr -3.52Cr -3.45Cr -147.9Cr -1.61Cr -1.16Cr -1.04Cr -95.21L -86.27L -109.74Cr -1.64Cr -11Cr -4.56Cr -58Cr -4.34Cr -4.25Cr -182.05Cr
Net Debt -1.52Cr -1.09Cr -97.32L -89.52L -81.11L -103.18Cr -1.54Cr -11Cr -4.29Cr -54Cr -4.08Cr -3.99Cr -171.17Cr -64.56L -46.27L -41.44L -38.12L -34.54L -44Cr -65.77L -4.55Cr -1.82Cr -23Cr -1.74Cr -1.7Cr -73Cr
Projected Income Statement - Annual - Light AI Inc.
Logo Light AI Inc.
Light AI Inc. is a technology company focused on developing artificial intelligence health screening and diagnostic solutions. It is engaged in developing screening and diagnostic solutions aimed at improving healthcare delivery worldwide. The Company is developing a technology platform which represents the next generation of patient management that it applies AI algorithms to smartphone images, starting with images of Strep A and anticipated expansion with COVID19 along with other medical conditions, to identify the disease in seconds. Its app-based solution requires no swabs, lab tests or proprietary hardware of any kind. Its AI powered technology offers screening and diagnostic tools designed to address critical healthcare challenges. Its technology offers a significant advancement in the identification of GAS pharyngitis. Its approach to applying AI to smartphone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin.
Employees
6
Date Price Change Volume
29/26/29 CA$0.0500 +11.11% 1,29,042
28/26/28 CA$0.0450 -25.00% 2,96,170
27/26/27 CA$0.0600 0.00% 34,684
26/26/26 CA$0.0600 -7.69% 50,410
23/26/23 CA$0.0650 +8.33% 72,795
  1. Stock Market
  2. Stocks
  3. ALGO Stock